The World Health Organisation has issued a stark warning that antimicrobial resistance Nigeria and other African nations face could claim millions more lives unless governments move swiftly from political pledges to concrete implementation. Speaking at a high-level global summit convened in Abuja this week, WHO officials revealed that bacterial drug resistance is already associated with more than 4.7 million deaths worldwide each year, a figure that threatens to climb dramatically without coordinated intervention across human health, animal husbandry, and environmental sectors. WHO Warning and Abuja Summit Context The three-day summit, which opened on Monday at the Transcorp Hilton, brings together health ministers from across the continent, representatives from the Africa Centres for Disease Control and Prevention, the Food and Agriculture Organisation, and the World Organisation for Animal Health. The gathering marks the first time Nigeria has hosted a global AMR forum of this magnitude, reflecting Abuja’s growing role in continental health diplomacy. Dr. Matshidiso Moeti, WHO Regional Director for Africa, told delegates that the gap between political commitments and actual implementation remains dangerously wide. “We have no shortage of declarations, resolutions, and action plans,” she said. “What we lack is the sustained financing, multisectoral coordination, and accountability mechanisms that turn paper promises into preserved antibiotics for future generations.” Nigeria’s Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, acknowledged the country’s dual burden as both a major contributor to and victim of the crisis. He cited recent data showing rising resistance rates for common pathogens like Klebsiella pneumoniae, Escherichia coli, and Staphylococcus aureus in tertiary hospitals across Lagos, Kano, and Port Harcourt. The Scale of the Crisis in Africa Sub-Saharan Africa bears a disproportionate share of the global AMR burden, with an estimated 27.3 deaths per 100,000 population directly attributable to drug-resistant infections, according to the most recent GRAM study published in The Lancet. Children under five and elderly patients in low-resource settings face the highest mortality risk, particularly from resistant bloodstream infections, pneumonia, and neonatal sepsis. In Nigeria alone, hospital-based surveillance networks have documented carbapenem-resistant Enterobacteriaceae in over 40% of intensive care unit isolates, rendering last-line antibiotics ineffective for many critically ill patients. The situation is compounded by limited diagnostic capacity — fewer than 15% of secondary health facilities have functional microbiology laboratories capable of conducting antimicrobial susceptibility testing. Dr. Chikwe Ihekweazu, former Director-General of the Nigeria Centre for Disease Control and now Assistant Director-General at WHO Geneva, emphasised that weak surveillance systems mask the true extent of the problem. “What we see in our reference laboratories is likely the tip of the iceberg,” he noted. “Without routine culture and sensitivity testing at the primary care level, we are essentially flying blind in much of the country.” Livestock Sector and Antibiotic Misuse A major focus of the Abuja summit is the veterinary dimension of the crisis. WHO projections indicate that global antimicrobial use in livestock could rise by 30% by 2040 if current trends continue, driven by intensifying animal protein demand across Africa and Asia. In Nigeria, the poultry and aquaculture sectors are expanding rapidly, often with minimal veterinary oversight and widespread use of critically important antibiotics as growth promoters. Professor Morenike Ukpong, a veterinary pharmacologist at the University of Ibadan, presented findings from a 2025 study detecting colistin-resistant E. coli in 18% of broiler chicken samples from live bird markets in Oyo and Ogun states. Colistin is a last-resort antibiotic for multidrug-resistant human infections, and its veterinary use has been banned or restricted in many jurisdictions. “The poultry value chain in Nigeria operates largely outside formal regulatory frameworks,” Ukpong explained. “Farmers purchase antibiotics over the counter without prescription, use them prophylactically, and observe no withdrawal periods before slaughter. The resistant bacteria then enter the food chain and environment through meat, manure, and wastewater.” The Federal Ministry of Agriculture and Rural Development has drafted regulations to restrict the use of medically important antimicrobials in food-producing animals, but enforcement remains weak due to insufficient veterinary personnel — Nigeria has approximately one veterinarian per 14,000 livestock units, far below the OIE recommended ratio. Nigeria’s Response and Policy Gaps Nigeria launched its second National Action Plan on AMR (2024–2028) last year, adopting a One Health approach that integrates human, animal, and environmental health sectors. The plan sets ambitious targets: establishing functional antimicrobial stewardship programmes in 50% of tertiary hospitals, reducing over-the-counter antibiotic sales by 40%, and achieving 80% compliance with veterinary prescription-only policies. However, implementation tracking reveals significant shortfalls. As of September 2026, only 12 of 52 federal tertiary hospitals have active antimicrobial stewardship committees with dedicated pharmacists and microbiologists. The Pharmacists Council of Nigeria reports that enforcement of prescription-only status for antibiotics remains inconsistent, with patent and proprietary medicine vendors continuing to dispense antimicrobials without prescriptions in many states. Funding constitutes another critical bottleneck. The national AMR secretariat operates on an annual budget of approximately ₦380 million, supplemented by donor support from the Fleming Fund and UK Aid. Stakeholders estimate that full implementation of the action plan requires at least ₦12 billion annually — a gap that neither federal nor state budgets have addressed. “We cannot rely indefinitely on external funding for a crisis that threatens our own health security,” said Dr. Tochi Okwor, Head of the AMR Programme at the Nigeria Centre for Disease Control. “Domestic resource mobilisation, including innovative financing mechanisms like health insurance reimbursement for stewardship activities, must be part of the solution.” Regional Collaboration and Next Steps The Abuja summit has produced a draft “Abuja Declaration on Accelerating AMR Action in Africa,” which commits signatories to several concrete measures: establishing a continental AMR surveillance network with standardised protocols, creating a pooled procurement mechanism for quality-assured antibiotics and diagnostics, and advocating for increased domestic health financing aligned with the Abuja Declaration target of 15% of national budgets. Ghana, Kenya, and South Africa have pledged to pilot a regional reference laboratory network that would provide confirmatory testing and genomic surveillance for priority pathogens. Rwanda and Ethiopia shared successful models of community-based antimicrobial stewardship that engage community health workers in monitoring antibiotic use and promoting adherence. Critically, the declaration calls for the African Union to elevate AMR to a standing agenda item at heads of state summits, ensuring sustained political attention beyond episodic conferences. “AMR is not a disease outbreak that comes and goes,” remarked Dr. Jean Kaseya, Director-General of Africa CDC. “It is a slow-moving pandemic that erodes the foundations of modern medicine. It demands the same political commitment we saw for HIV, malaria, and COVID-19.” What This Means for Ordinary Nigerians For the average Nigerian, the consequences of unchecked antimicrobial resistance are already tangible. A course of antibiotics that once cost ₦2,000 for a simple urinary tract infection may now require second- or third-line agents costing ten times as much — often unavailable in public facilities and unaffordable for many households. Surgical procedures, cancer chemotherapy, and care for premature infants all become riskier when prophylactic antibiotics lose efficacy. Mrs. Fatima Bello, a trader in Abuja’s Garki Market, described her experience: “My son had typhoid last year. The first antibiotics didn’t work. The doctor changed to stronger ones — we spent over ₦45,000 on drugs alone. Many people cannot afford this. They buy incomplete doses from chemists, which only makes the problem worse.” Public awareness campaigns launched during World Antimicrobial Awareness Week have begun to shift behaviours, but misconceptions persist. A 2025 NCDC survey found that 62% of respondents believed antibiotics could treat viral infections like colds and flu, while 48% reported stopping antibiotics once symptoms improved rather than completing the prescribed course. Pharmacists and community health workers are emerging as critical frontline stewards. The Pharmaceutical Society of Nigeria has trained over 3,000 community pharmacists on antimicrobial stewardship principles since 2023, equipping them to counsel patients, refuse inappropriate requests, and refer suspected resistant infections for culture testing. Frequently Asked Questions What is antimicrobial resistance and why does it matter? Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites evolve to withstand the medicines designed to kill them. This makes common infections harder to treat, increases the risk of disease spread, severe illness, and death. For Nigeria, it threatens to undo decades of progress in child survival, maternal health, and infectious disease control. How can I help prevent antimicrobial resistance? Only use antibiotics when prescribed by a qualified health professional. Complete the full prescribed course even if you feel better. Never share or use leftover antibiotics. Practice good hygiene — regular handwashing, safe food preparation, and up-to-date vaccinations reduce the need for antibiotics in the first place. Is the Nigerian government doing enough to address this crisis? Nigeria has developed comprehensive policies including a One Health National Action Plan, but implementation gaps persist due to funding shortfalls, weak enforcement of prescription regulations, and limited laboratory capacity. The Abuja summit aims to catalyse stronger domestic financing and multisectoral accountability to close these gaps. Source: Vanguard Nigeria – AMR: WHO warns of 4.7m deaths, demands urgent action as Abuja hosts global summit Related Reading African Union latest updates you need to know Related posts: WHO Confirms No Vaccine or Specific Treatment for New Ebola Strain in Nigeria WHO Clarifies: Nigeria Still Not Declared Ebola–free Ondo Herbal Drink Tragedy Claims 48 Lives, Leaves Hundreds Hospitalised Pneumonic Plague Risk: What You Need to Know After Russia Lab Death Report Post navigation Seven Global Partners Commit $65 million to Maternal Health Funding Nigeria and Slash Maternal and Newborn Deaths NAFDAC Seizes Unregistered Cosmetics Nigeria and Fake Medicines at Lagos Trade Fair Complex